Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

NASDAQ:GBIO

Generation Bio Co.

Last Close

2.63

25/09 14:26

Market Cap

155.01M

Beta: 1.96

Volume Today

3.61K

Avg: 496.01K

PE Ratio

−1.04

PFCF: −2.25